Bachem stock gains as JPMorgan raises price target to 90 CHF

Published on 09/11/2026 at 13:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bachem stock is supported by fresh analyst action after JPMorgan lifted its price target to 90 CHF on September 10, 2026, a 5.9 percent increase. The shares recently traded around 79 CHF on SIX Swiss Exchange, close to the upper end of the 52-week range.

Fotorealistische Peptid-Produktionsanlage mit Alpenpanorama im Hintergrund — Bachem Holding AG (CH0012530207) betreibt moderne Peptid-Produktionsanlagen mit Bioreaktoren vor Schweizer Alpenpanorama, Illustration mit AI erstellt.

Bachem Holding AG stock (ISIN CH0012530207) is trading near the top of its recent range after JPMorgan raised its price target from 85 CHF to 90 CHF on September 10, 2026, reinforcing an Overweight rating and signaling greater confidence in the company’s earnings potential.

JPMorgan lifts Bachem price target

According to Ad-hoc-news summarizing JPMorgan research on September 10, 2026, the bank raised its price target for Bachem from 85 CHF to 90 CHF and reiterated an Overweight rating, marking a 5.9 percent increase in the target and underscoring a positive view on the company’s earnings trajectory.

This move by JPMorgan comes against the backdrop of other analyst opinions, with Ad-hoc-news reporting that Barclays analyst Charles Pitman maintained a Hold rating and an unchanged price target of 80.00 CHF on September 9, 2026, even as the stock traded around 78 to 79 CHF on SIX Swiss Exchange that day.

Stock trades near upper end of 52-week range

Per data summarized from SIX Swiss Exchange via Ad-hoc-news, Bachem stock most recently closed at 78.40 CHF on SIX Swiss Exchange on September 9, 2026, placing the shares close to the upper end of a stated 52-week range between 50.00 CHF and 83.80 CHF.

More recent intraday data from finanzen.ch show that on September 10, 2026, the Bachem share rose by 2.2 percent to 79.15 CHF at 4:28 p.m. local time on SIX Swiss Exchange, after starting the day at 80.00 CHF and reaching an intraday high of 80.90 CHF.

On September 11, 2026, finanzen.ch reported that the SIX session for Bachem began at a price of 79.15 CHF and that 3,005 shares had been traded by late morning, indicating continued investor interest around the high-70s price region.

Valuation and earnings expectations

The recent analyst actions and price behavior are being viewed in light of earnings expectations for the current year. As finanzen.ch notes, experts expect earnings per share of 2.40 CHF for Bachem in fiscal year 2026, a figure that provides a reference point for investors assessing whether the current price near 79 CHF leaves further upside to the newly raised 90 CHF target.

For investors, the relationship between the current share price and the analyst targets is a key signal. With the stock closing at 78.40 CHF on September 9, 2026 and JPMorgan’s new target at 90 CHF, the implied upside to that target is around 14.8 percent, while the Barclays target of 80.00 CHF sits only about 2 percent above that same closing level, illustrating the spread between a more cautious and a more optimistic view on the shares.

Stock remains supported by SPI index context

Bachem’s recent performance also stands out within the Swiss Performance Index (SPI). In an overview of SPI constituents, finanzen.net highlighted Bachem among the stronger stocks, citing a gain of 2.39 percent to 79.30 CHF in one recent SPI session.

This index context matters because it shows that Bachem stock has not only reacted to specific analyst actions but has also participated in broader sector and market moves, which can affect how quickly investor sentiment shifts when new research or company news emerges.

Bachem stock price snapshot and investor angle

As of the latest available data around September 11, 2026, Bachem stock is trading on SIX Swiss Exchange close to 79.00 CHF, after a prior close of 79.15 CHF on September 10, 2026, with daily swings taking the shares as high as 80.90 CHF in recent sessions; this places the price near the upper end of the 52-week range between 50.00 CHF and 83.80 CHF and below the 90 CHF price target set by JPMorgan.